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Survival differences for non-Bronchioloalveolar Carcinoma (BAC) non-small-cell lung cancer (NSCLC) cases with ipsilateral intrapulmonary metastasis at diagnosis
Zell, Jason A; Ou, Sai-Hong-lgnatius; Ziogas, Argyrios; Anton-Culver, Hoda
Universi ty o f Cal if ornia, Irvine, CA, USA Background: Survival advantages have been demonstrated for advanced BAC patients with ipsilateral intrapulmonary metastasis at diagnosis, but it is not known whether these differences manifest in non-BAC NSCLC patients.
Methods:
We conducted a case-only analysis of U.S. Surveillance, Epi demiology, and End Results (SEER) data (1999) (2000) (2001) (2002) (2003) . Overall survival (OS) and lung cancer-specific survival (LCSS) univariate analyses were conducted using the Kaplan-Meier method. Multivariate survival analy ses were performed using Cox proportional hazards ratios.
Results: 46,169 incident cases of histologically-confirmed non-BAC
NSCLC with complete TNM staging information available were identi fied, including large cell carcinoma (LCC, n=1826, or 6.7%), squamous cell carcinoma (SqCC, n=5956, or 21.7%), undifferentiated carcinoma (n=8754, or 31.9%), and adenocarcinoma (n=l0,899, or 39.7%). The majority of these NSCLC cases had advanced stage at presentation (stage I, n=ll,106; stage II, n=1908; stage Illa, n=5720; stage Illb, n=7845; stage IV, n=l 9,590). Cases with stage IIIB non-BAC-NSCLC due to multiple lesions in the same lobe (n=633) had significantly improved median OS (21 m) and LCSS (31m) compared to other stage IIIB NSCLC cases (n=7212; OS = 8 m, LCSS =9 m) (P<0.0001 for both OS and LCSS comparisons) ( Figure 1 ). Among stage IV NSCLC cases, those with intrapulmonary metastasis (n=3010) had significantly improved median OS (9m) and LCSS (llm) compared to those with distant metastasis (n=16,580; OS = 5m, LCSS = 6m) (P<0.0001 for both comparisons) ( Figure 2 ). These survival differences persisted after Conclusions: Among stage IIIB and N NSCLC cases, those present ing with ipsilateral intrapulmonary metastasis have improved survival outcomes. Our results add further support for modification to the cur rent non-small-cell lung cancer staging system.
Copyright© 2007 by the International Association for the Study of Lung Cancer

